Schedule 13D ownership disclosure

AILERON THERAPEUTICS INC

Security class unavailable · CUSIP: 00887A105

Event date: 2017-07-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001596770-17-000019
Form type
SC 13D
Filer
Rein Therapeutics, Inc.
CIK
CIK 1420565
Filed
Jul 17, 2017
Reporting period
Jul 05, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub